---
title: "Epinephrine - Open-Angle Glaucoma"
sidebar: mydoc_sidebar
permalink: db00668-mesh-d005902-1.html
toc: false 
---


Path ID: `DB00668_MESH_D005902_1`
{% include image.html url="images/db00668-mesh-d005902-1.png" file="db00668-mesh-d005902-1.png" alt="db00668-mesh-d005902-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| <a href="https://identifiers.org/MESH:D004837">MESH:D004837 </a> | epinephrine | Drug |
| <a href="https://identifiers.org/UniProt:P35348">UniProt:P35348 </a> | Alpha-1A adrenergic receptor | Protein |
| <a href="https://identifiers.org/UniProt:P35368">UniProt:P35368 </a> | Alpha-1B adrenergic receptor | Protein |
| <a href="https://identifiers.org/UniProt:P25100">UniProt:P25100 </a> | Alpha-1D adrenergic receptor | Protein |
| <a href="https://identifiers.org/reactome:R-HSA-416476﻿">reactome:R-HSA-416476﻿ </a> | G alpha (q) signalling events | Pathway |
| <a href="https://identifiers.org/reactome:R-HSA-416482﻿">reactome:R-HSA-416482﻿ </a> | G alpha (12/13) signalling events | Pathway |
| <a href="https://identifiers.org/GO:0042310">GO:0042310 </a> | vasoconstriction | BiologicalProcess |
| <a href="https://identifiers.org/UBERON:0001796">UBERON:0001796 </a> | aqueous humor of eyeball | GrossAnatomicalStructure |
| <a href="https://identifiers.org/HP:0007906">HP:0007906 </a> | Ocular Hypertension | PhenotypicFeature |
| <a href="https://identifiers.org/MESH:D005902">MESH:D005902 </a> | Open-angle glaucoma | Disease |
|------------|------|---------|

## Relationships


NOTE: predicates are annotated in <a href="https://github.com/biolink/biolink-model/releases/tag/v1.3.0">Biolink Model (v1.3.0)</a>

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Epinephrine | INCREASES ACTIVITY OF | Alpha-1A Adrenergic Receptor |
| Epinephrine | INCREASES ACTIVITY OF | Alpha-1B Adrenergic Receptor |
| Epinephrine | INCREASES ACTIVITY OF | Alpha-1D Adrenergic Receptor |
| Alpha-1D Adrenergic Receptor | PARTICIPATES IN | G Alpha (Q) Signalling Events |
| Alpha-1A Adrenergic Receptor | PARTICIPATES IN | G Alpha (Q) Signalling Events |
| Alpha-1B Adrenergic Receptor | PARTICIPATES IN | G Alpha (Q) Signalling Events |
| Alpha-1D Adrenergic Receptor | PARTICIPATES IN | G Alpha (12/13) Signalling Events |
| Alpha-1A Adrenergic Receptor | PARTICIPATES IN | G Alpha (12/13) Signalling Events |
| Alpha-1B Adrenergic Receptor | PARTICIPATES IN | G Alpha (12/13) Signalling Events |
| G Alpha (Q) Signalling Events | POSITIVELY REGULATES | Vasoconstriction |
| G Alpha (12/13) Signalling Events | POSITIVELY REGULATES | Vasoconstriction |
| Vasoconstriction | NEGATIVELY CORRELATED WITH | Aqueous Humor Of Eyeball |
| Aqueous Humor Of Eyeball | POSITIVELY CORRELATED WITH | Ocular Hypertension |
| Ocular Hypertension | POSITIVELY CORRELATED WITH | Open-Angle Glaucoma |
|---------|-----------|---------|

Comment: DrugBank (https://go.drugbank.com/drugs/DB00668) has this drug modulating beta receptors but not for glaucoma. For this indication, the ligand should be an antagonist (and epinephrine is an agonist instead).

Reference: 
  - [https://en.wikipedia.org/wiki/Glaucoma#Medication](https://en.wikipedia.org/wiki/Glaucoma#Medication)
  - [https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL679/](https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL679/)
